Affiliation:
1. Ribi ImmunoChem Research, Inc., Hamilton, Montana, USA
Abstract
This review article addresses the question of whether or not monophosphoryl lipid A offers a therapeutic advantage over smaller doses of endotoxin. Biological data were collected from a literature review and these were used to calculate therapeutic indices for monophosphoryl lipid A and endotoxin. Subsequent calculations yielded results which showed that, in humans and in other animals, monophosphoryl lipid A did have a therapeutic advantage over smaller doses of endotoxin.
Subject
Infectious Diseases,Cell Biology,Molecular Biology,Immunology,Microbiology
Reference67 articles.
1. General Characteristics
2. ENDOTOXINS AND DISEASE MECHANISMS
3. Reitschel ET, Braude H., Braude L. et al. Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. In: Detection of bacterial endotoxins with the Limulus amebocyte lysate test. New York: Alan R Liss, 1987: 25-53.
4. DISSOCIATION OF ANTITOXIC AND IMMUNOGENIC ACTIVITIES OF ENDOTOXIN BY ACETYLATION
5. Stimulation of Nonspecific Resistance by Radio-Detoxified Endotoxin
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献